Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis
Project: IMMUNOSTIM
Updated at: 27-04-2024
Show more
information
Project acronym
IMMUNOSTIM